NCT04218708
Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS
Sponsored by NYU Langone Health
This is a research study to understand and determine the effectiveness of electronic cigarettes versus nicotine replacement therapy in adults who smoke and also live with HIV/AIDS in effort to reduce cigarette smoking.
Inclusion Criteria: * Current Combustible Cigarette (CC) smokers (more than 5 packs in a lifetime; smokes 4 or more days/week), * Smokes at least 10 cigarettes per day on days they smoke CC. * Motivated to quit smoking (at least a 5 on a 10-point Likert scale). * Must be able to provide consent * Agree to be randomized and followed-up with, * Reside in New York City * Be willing to use an e-cigarette or NRT for 12 weeks. Exclusion Criteria: * Are pregnant (as determined by urine test) or breastfeeding (self-reported), * State diagnosis of any medical condition (angina/heart disease) precluding use of nicotine patch or gum, or by self-report in screening questionnaire * Reporting using NRTs or e-cigarettes or within the last 30 days * Have untreated/are undergoing current treatment for psychiatric illness or cognitive impairment at time of initial screening as determined by the subjects' primary care doctor or a licensed study team member in screening * Report a history of severe or untreated cardiopulmonary disease such as asthma or emphysema.
NYU Langone Health
New York, New York, United States
Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.
Interested in this trial?
Express your interest and we'll connect you with the trial team.
Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.
Conditions